| | | Insertion | IMMUNODEFICIENCY 127 | |
| | | Single nucleotide variant (missense variant) | not specified | |
| | | Single nucleotide variant (missense variant) | not specified | |
| | | Single nucleotide variant (missense variant) | not specified | |
| | | Duplication | Proteasome-associated autoinflammatory syndrome 1 | |
| | | Duplication | not provided | |
| | | Single nucleotide variant (missense variant) | not specified | |
| | | Single nucleotide variant (missense variant) | Migraine with or without aura, susceptibility to, 1 | |
| | | Copy number gain | not specified | |
| | | Single nucleotide variant | Susceptibility to severe coronavirus disease (COVID-19) due to high plasma levels of TNF, TNFR, and/or TNFR5 +1 more | |
| | | Deletion | Megacolon | |
| | | Copy number gain | not provided | |
| | | Single nucleotide variant (synonymous variant) | not provided | |
| | | Single nucleotide variant (missense variant) | not provided | |
| | | Single nucleotide variant (synonymous variant) | not provided | |
| | | Single nucleotide variant (synonymous variant) | not provided | |
| | | Single nucleotide variant (synonymous variant) | not provided | |
| | | Single nucleotide variant (synonymous variant) | not provided | |
| | | Copy number gain | not provided | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Single nucleotide variant | etanercept response - Efficacy | |
| | ILRUN-AS1, IP6K3 +2582 more | Copy number gain | See cases | |
| | | Single nucleotide variant | Alzheimer disease, protection against | |
| | | Single nucleotide variant | | |
| | | Single nucleotide variant | Malaria, cerebral, susceptibility to | |
| | | Single nucleotide variant (missense variant) | TNF receptor binding, altered | |
| | | Variation | TNF receptor binding, altered | |